Seqirus

AFLURIA QUADRIVALENT 0.25ML (2019/2020)

Manufacturer:

Seqirus

Afluria Quadrivalent HCPCS:

90687

HCPCS Code Descriptor:

Category:

CPT Drug Code

Afluria Quadrivalent NDCs:

33332-0423-10

Primary Type:

Vaccine

Generic/Specialty Status:

Single-Source

Route of Administration:

Intramuscular

Potential NDC Listing Errors:

Our team has identified potential listing errors/discrepancies with the following NDCs:

33332-0423-10

About Afluria Quadrivalent:

AFLURIA QUADRIVALENT 0.25ML (2019/2020) is a Vaccine drug manufactured by Seqirus and administered via the Intramuscular route of administration. The CPT Drug Code: 90687 is aligned to the drug AFLURIA QUADRIVALENT 0.25ML (2019/2020).

ACCESS PRICING AND MORE BY REGISTERING

90687 Added Date:

NA

90687 Effective Date:

NA

90687 Termination Date:

HCPCS Active

We have not yet identified a manufacturer source of Afluria Quadrivalent 0.25Ml (2019/2020) billing and coding information.
Our team did not identify a source for Afluria Quadrivalent 0.25Ml (2019/2020) patient assistance information. Please reach out to our team if you feel that this is a mistake.
AFLURIA QUADRIVALENT 0.25ML (2019/2020) prescribing information can be found at the link below:
Our team has not yet identified a source of side effects information for AFLURIA QUADRIVALENT 0.25ML (2019/2020). Please check back in a few weeks.